Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S7 pseudogene 13 (RPS7P13) is a processed pseudogene derived from the ribosomal protein S7 (RPS7) gene. Pseudogenes like RPS7P13 are noncoding DNA sequences that resemble functional genes but typically lack coding potential due to disruptive mutations, truncations, or absence of regulatory elements required for protein expression[6]. The RPS7 gene encodes a component of the 40S ribosomal subunit that is essential for protein synthesis, but RPS7P13 does not encode a functional protein[1][3]. Most pseudogenes, including RPS7P13, are considered nonfunctional "dead" genomic elements, though a minority have been shown to exert regulatory effects on gene expression[6]. There is no evidence that RPS7P13 is biologically active or implicated in disease, nor is it a target for therapeutic intervention.\n\nAdditional notes:\n- If your goal is structured drug discovery or target databases, only the functional parent gene (RPS7) should be considered; pseudogenes like RPS7P13 do not fulfill the criteria for therapeutic targets[3][6].\n- If you intended to refer to the active ribosomal protein S7 itself, consider using "Ribosomal protein S7" (RPS7) instead[1][3].\n\nSummarized clarification:\n- "Ribosomal protein S7 pseudogene 13" is a pseudogene, not a protein, receptor, enzyme, or recognized drug target.\n- There are no known biological functions, drug interactions, disease roles, or biomarker uses for RPS7P13.\n- Entry is best classified as "not a therapeutic target" and "not functionally characterized"[6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S7 pseudogene 13 (RPS7P13).